BAX:NYSE
Baxter International Inc
25,62 $
arrow_downward
−0,45%(−0,11) 1 p
13. nov, 10:12:24 GMT −5 · USD
search
Kõik sümbolid
| Sümbol | Hind | Muutus | % muutus |
|---|
insights_autoÜksuse BAX põhistatistika genereerimine…
Ava
25,90 $
Kõrge
25,90 $
Madal
25,43 $
Turu kapit.
13,25 mld
Keskm. maht
6,84 mln
Maht
206,25 tuh
Dividend
0,16%
Kvartaalne dividend
0,01 $
Dividendikuupäev
27. nov 2026
52 näd kõrgeim
30,00 $
52 näd madalaim
15,73 $
Aktsiatulu
−1,42 $
Beeta
0,68
Käibivad aktsiad
517,35 mln
Töötajate arv
38 tuh
Ava
25,90 $
Kõrge
25,90 $
Madal
25,43 $
Turu kapit.
13,25 mld
Keskm. maht
6,84 mln
Maht
206,25 tuh
Dividend
0,16%
Kvartaalne dividend
0,01 $
Dividendikuupäev
27. nov 2026
52 näd kõrgeim
30,00 $
52 näd madalaim
15,73 $
Aktsiatulu
−1,42 $
Beeta
0,68
Käibivad aktsiad
517,35 mln
Töötajate arv
38 tuh
Uudised
Veebiallikatest ja uudistepartneritelt
News Corp
·
16 tunni eest
Baxter International Inc. stock underperforms Thursday when compared to competitors
Yahoo Finance
·
1 päeva eest
Baxter International Inc. (BAX) Stock Forecasts
MarketWatch
·
3 päeva eest
Baxter International Inc. stock outperforms competitors on strong trading day
Profiil
Baxter International Inc. is an American multinational healthcare company with headquarters in Deerfield, Illinois.
The company primarily focuses on products to treat chronic and acute medical conditions. The company had 2023 global net sales of $14.8 billion, across three business: "Medical Product and Therapies", "Healthcare Systems and Technologies" and Pharmaceuticals.
Baxter's Medical Product and Therapies business comprise two divisions: the first named "Advanced Surgery" that produce technologies to enhance surgeons' technique, increase efficiencies and improve outcomes. The second named "Infusion Therapies and Technologies" produces intravenous products and other products used in the delivery of fluids and drugs to patients.
Baxter's Healthcare System and Technologies business has four divisions "Front Line Care", "Digital Platform and Innovations", "Care and Connectivity Solutions" and "Global Services".
Baxter's Pharmaceuticals business produce inhalational anaesthetics and other differentiated hospital pharmaceuticals in areas of pain, critical care, anti-infection and oncology. Wikipedia
Teave üksuse Baxter International Inc kohta
TegevjuhtAndrew Hider
Töötajad37,5 tuh
Asutatud1931
PeakontoridDeerfield, Illinois, Ameerika Ühendriigid
SektorHealth Care
Valdkond-
Veebisaitbaxter.com